DarioHealth Corp.

Greetings and welcome to the Dario Hell fourth quarter 2023 results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Kat Perrella, Investor Relations Manager.

Thank you, operator, and good morning, everybody. Thank you for joining us today for a discussion of Dario Health's fourth quarter and full year 2023 financial results. Leading the call today will be Erez Rafael, CEO of Dario Health. He'll be joined by Rick Anderson, President. After the prepared remarks, we will open the call for Q&A, where we will be joined by TWIL co-founders, Tomer Ben-Kiki and Ofer Leibner. In audio recording and webcast replay for this call will also be available online as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Thursday, March 28, 2024. This morning, we issued a press release announcing our financial results for the fourth quarter and full year 2023. A copy of the release can be found on the investor relations page of Dario Health's website. Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand, or the competitive nature of Dario Health's industry. Such forward-looking statements and their implications may involve known and unknown risks, uncertainties, and other factors that may cause actual results or performance to differ materially from those projected. The forward-looking statements discussed on this call are subject to other risks and uncertainties, including those discussed in the risk factors section and elsewhere in the company's full year 2023 annual report on Form 10-K. Additional information concerning factors that could cause results to differ materially from our forward-looking statements are described in greater detail on the company's press release issued this morning and in the company's other filings with the SEC. In addition, certain non-GAAP financial measures may be discussed during this call. These non-GAAP measures are used by management to make strategic decisions, forecast future results, and evaluate the company's current performance. Management believes the presentation of these non-GAAP financial measures is useful for investors' understanding and assessment of the company's ongoing core operations and prospects for the future. A reconciliation of these non-GAAP measures to the most comparable GAAP measures is included in this morning's press release. With that, I'd like to introduce Erez Rafael, Chief Executive Officer of Dario Health. Erez.

Thank you, Kat, and thanks to all of you for joining our call this morning. 2023 financial results are a continuation of our multi-year strategy and the evolution of our financial profile that is now being accelerated with accounts that are launching and accelerated further with the . Before analyzing the potential contribution of Aetna and other accounts that we launched in Q1 and that we'll continue to launch in Q2, I would like to first remind you of the three revenue streams which remain the same post the acquisition as we operate in the same channels. First is our historical direct-to-consumer or B2C business. Second is our core business, the recurring revenue from health plans and employers, or what we call commercial B2B2C, with clients like Blue Shields California, Aetna CVS. In Quill case, it's clients like Cigna, Elevance, Amazon, Google, and others.